Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility

L. M. Osborn, C. Lenarsky, R. C. Oakes, M. I. Reiff

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Current guidelines for treatment of hemolytic disease of the newborn make no differentiation between ABO and Rh incompatibility. A protocol that prolonged the observation period in full-term, ABO-incompatible infants with positive Coombs' tests who were otherwise healthy was tested. Postponement of treatment made it possible to determine more accurately which infants needed phototherapy. This dramatically decreased the number of infants treated without increasing their risk of requiring exchange transfusion.

Original languageEnglish (US)
Pages (from-to)371-374
Number of pages4
JournalPediatrics
Volume74
Issue number3
StatePublished - Jan 1 1984

Fingerprint Dive into the research topics of 'Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility'. Together they form a unique fingerprint.

Cite this